Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Vivos Therapeutics (VVOS) Other Gross PP&E Adjustments (2019 - 2025)

Vivos Therapeutics' Other Gross PP&E Adjustments history spans 7 years, with the latest figure at $1.3 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $1.3 million for Q4 2025, down 70.32% from a year ago — trailing twelve months through Dec 2025 was $1.3 million (down 70.32% YoY), and the annual figure for FY2025 was $1.3 million, down 70.32%.
  • Other Gross PP&E Adjustments for Q4 2025 was $1.3 million at Vivos Therapeutics, down from $4.8 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $4.9 million in Q3 2024 to a low of $1.3 million in Q4 2025.
  • The 5-year median for Other Gross PP&E Adjustments is $3.7 million (2021), against an average of $3.5 million.
  • The sharpest move saw Other Gross PP&E Adjustments soared 139.38% in 2021, then plummeted 70.32% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at $2.5 million in 2021, then dropped by 7.18% to $2.4 million in 2022, then soared by 57.49% to $3.7 million in 2023, then grew by 18.37% to $4.4 million in 2024, then plummeted by 70.32% to $1.3 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $1.3 million, $4.8 million, and $4.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.